Amye Black

Amye Black is a Principal Scientist at Akebia Therapeutics, having joined the company in December 2021, with previous roles as Senior Scientist and Scientist II. Prior to this position, Amye worked as a Scientist I at Beantown Biotech from November 2020 to December 2021. Amye's academic journey includes significant experience at the University of Massachusetts Amherst, where roles included Graduate Teaching Assistant and Graduate Research Assistant, focusing on breast cancer research under the guidance of Joseph Jerry, PhD, and Karen Dunphy, PhD. Additionally, Amye served as a Graduate Teaching Assistant in anatomy and physiology and introductory biology courses. Amye's early research experience includes an undergraduate role at the University of Connecticut, completing a thesis on the Celf4 splicing factor. Amye holds a PhD in Molecular & Cellular Biology from the University of Massachusetts Amherst and a Bachelor of Science in Molecular Biology from the University of Connecticut.